Menquadfi Solution for Injection (IM)

Ülke: Filipinler

Dil: İngilizce

Kaynak: FDA (Food And Drug Administration)

Aktif bileşen:

Meningococcal Group A, C, W-135 and Y Conjugate Vaccine

Mevcut itibaren:

N/A; Importer: Sanofi Pasteur, Inc.; Distributor: Zuellig Pharma Corporation

INN (International Adı):

Meningococcal Group A, C, W-135 and Y Conjugate Vaccine

Doz:

Formulation: Each dose (0.5 mL) contains: Neisseria meningitidis group A polysaccharide* .... 10 mcg Neisseria meningitidis group C polysaccharide* .... 10 mcg Neisseria meningitidis group Y polysaccharide* .... 10 mcg Neisseria meningitidis group W-135 polysaccharide* .... 10 mcg *Conjugated to Tetanus Toxoid carrier protein... 55 mcg** **Tetanus Toxoid quantity is approximate and dependent on the polysaccharide to protein ratio for the conjugates in each formulation

Farmasötik formu:

Solution for Injection (IM)

Paketteki üniteler:

Single dose. 0.5 mL in 2 mL USP Type I glass vial with gray chlorobutyl rubber stopper sealed with aluminum and black plastic flip-off cap (Box of 1's and 5's), Single dose. 0.5 mL in 2 mL USP Type I glass vial with gray chlorobutyl rubber stopper sealed with aluminum and black plastic fl

Tarafından üretildi:

Sanofi Pasteur, United States of America

Ürün özeti:

Formulation: Each dose (0.5 mL) contains: Neisseria meningitidis group A polysaccharide* .... 10 mcg Neisseria meningitidis group C polysaccharide* .... 10 mcg Neisseria meningitidis group Y polysaccharide* .... 10 mcg Neisseria meningitidis group W-135 polysaccharide* .... 10 mcg *Conjugated to Tetanus Toxoid carrier protein... 55 mcg** **Tetanus Toxoid quantity is approximate and dependent on the polysaccharide to protein ratio for the conjugates in each formulation

Yetkilendirme tarihi:

2022-03-04